AMRX 7.78 (+0.39%)
US03168L1052Drug ManufacturersDrug Manufacturers - Specialty & Generic

Amneal Pharmaceuticals (AMRX) Financial Metrics

This table shows a selected set of financial data points of Amneal Pharmaceuticals (AMRX). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.48 0 -12.73 1.07B -0.02 2.39B 276.39M 417.96M -83.99M 91.54M
2022 -0.86 0 -2.31 300.38M -0.03 2.21B -25.5M 446.64M -129.99M 25.98M
2021 0.07 0 67.18 713.34M 0 2.09B 189.18M 442.64M 10.62M 247.79M
2020 0.62 0 7.4 673.81M 0.02 1.99B 312.82M 349.06M 91.06M 341.38M
2019 -2.74 0 -1.76 636.75M -0.09 1.63B -95.73M 69.81M -361.92M 151.2M
2018 -1.33 0 -10.14 1.72B -0.06 1.66B 153.14M 109.83M -169.73M 213.39M
2017 1.46 0 0 0 0.11 1.03B 119.92M 286.64M 167.65M 74.17M
2016 1.81 0 0 0 0.11 1.02B -9.55M 301.07M 207.38M 180.13M
2015 0.54 0 0 0 0.04 860.47M 0 0 39M 340.35M
2014 2.49 0 0 0 0 785.62M 0 0 176.93M 0
2013 0 0 0 0 0 0 0 0 0 0
2012 0 0 0 0 0 0 0 0 0 0
2011 0 0 0 0 0 0 0 0 0 0
2010 0 0 0 0 0 0 0 0 0 0
2009 0 0 0 0 0 0 0 0 0 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.